Skip to content

Rotational Stability of a Hydrophobic Acrylic Plate Haptic Intraocular Lens Using a Capsular Tension Ring - An Intraindividual Comparative Study

Rotational Stability of a Hydrophobic Acrylic Plate Haptic Intraocular Lens Using a Capsular Tension Ring - An Intraindividual Comparative Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04226196
Acronym
ConTRol
Enrollment
65
Registered
2020-01-13
Start date
2020-01-27
Completion date
2021-04-30
Last updated
2020-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capsular Tension Ring, Intraocular Lens Rotation

Keywords

Intraocular lens rotation, capsular tension ring, postoperative tilt & decentration

Brief summary

The present study should investigate the influence of a capsular tension ring on postoperative rotational stability of a plate haptic hydrophilic acrylic intraocular lens. All patients will be operated on both eyes in one occasion. Both eyes receive a Zeiss 409MP plate haptic intraocular lens, while only on eye receives an additional capsular tension ring. Follow up visits take place 1 hour, 1 week, 1 month and 4 to 7 months after surgery. At the follow up visits, the actual IOL axis will be determined by retroillumination photography. IOL centration and tilt will be determined by anterior segment SS-OCT Casia II. IOLs will be implanted in 4 different axis 0 +/- 10 degrees, 45 +/- 10 degrees, 90 +/- 10 degrees, 135 +/- 10 degrees. IOL rotation, decentration and tilt then will be compared intraindividually.

Interventions

Implantation of an intraocular lens Zeiss 409 MP into the capsular bag using an injector, after removing of the human crystalline lens.

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Investigator will be masked to which axis the IOL will be implanted until a sealed envelope will be opened in the operating theater.

Eligibility

Sex/Gender
ALL
Age
45 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Bilateral age-related cataract necessitating phacoemulsification extraction and posterior IOL implantation * Need for spherical IOL correction between +0.00 and +32.00 D * Pupil dilation of ≥ 7.0 mm * Age 45 to 95

Exclusion criteria

* Corneal abnormality (Corneal scaring) * Preceding ocular surgery or trauma * Uncontrolled glaucoma * Proliferative diabetic retinopathy * Iris neovascularization * History of uveitis/iritis * Microphthalmus * Recurrent intraocular inflammation of unknown etiology Uncontrolled systemic or ocular disease * Pregnancy * Lactation

Design outcomes

Primary

MeasureTime frameDescription
Change of axial intraocular lens position7 monthsChange in axis position of an intraocular lens Zeiss 409 MP from end of surgery (baseline axis) to 1 hour, 1 week, 1 month and 4-7 months (end of study visit). The change in axis position will be evaluated with respect to the baseline measurement at the end of surgery. Differences in axis position will be described as rotation in degrees (0 to 360°)

Secondary

MeasureTime frameDescription
Decentration7 monthsDecentration of the intraocular lens will be measured with the Casia 2 OCT. Decentration will be described as Decentration in millimeter
Tilt7 monthsTilt of the intraocular lens will be measured with the Casia 2 OCT. Tilt will be described as Tilt in degrees at a certain axis
Anterior chamber depth7 monthsThe anterior chamber depth (Axial position of the IOL) of the intraocular lens will be measured with the Casia 2 OCT after 1 month. The anterior chamber depth will be measured in millimeter
Best corrected visual acuity (BCVA)7 monthsBCVA will be measured at 1 week, 1 month and 4 to 7 months. The BCVA will be described as the minimum angle of resolution (logMar)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026